22468 Results

People

  1. Ladanyi
    Ladanyi
  2. Antonescu
    Antonescu
  3. Offit
    Offit
  4. Solit
    Solit
  5. Levine
    Levine
  6. Berger
    Berger
  7. O'Reilly
    O'Reilly
  8. Cheung
    Cheung
  9. Reis-Filho
    Reis-Filho
  10. Abdel-Wahab
    Abdel-Wahab

Groups

  1. GSK Faculty (22468)
  2. Sloan Kettering Institute Faculty (11482)
  3. Department of Medicine (10529)
  4. Tow Center for Developmental Oncology (TCDO) (6948)
  5. Sloan Kettering Institute Postdocs (6210)
  6. Solid Tumor Oncology Division (5880)
  7. Human Oncology and Pathogenesis Program (5697)
  8. Center for Hematologic Malignancies (5359)
  9. Center for Molecular Imaging and Biotechnology (5298)
  10. Department of Pathology and Laboratory Medicine (4773)
  1. "GSK Faculty"
Formats
  1. Journal Article (13834)
  2. Meeting Abstract (7076)
  3. Review (514)
  4. Book Section (342)
  5. Editorial (307)
  6. Conference Paper (162)
  7. Research Letter (96)
  8. Miscellaneous (45)
  9. Correspondence (38)
  10. Guidelines (32)
  11. Book Whole (22)
Groups
  1. GSK Faculty (22468)
  2. Sloan Kettering Institute Faculty (11482)
  3. Department of Medicine (10529)
  4. Tow Center for Developmental Oncology (TCDO) (6948)
  5. Sloan Kettering Institute Postdocs (6210)
  6. Solid Tumor Oncology Division (5880)

More Groups

People
  1. Marc Ladanyi (1327)
  2. Steven Larson (957)
  3. Jedd Wolchok (905)
  4. Cristina Antonescu (895)
  5. Kenneth Offit (788)
  6. David Solit (779)

More People

Years
  1. 2025 (296)
  2. 2024 (868)
  3. 2023 (1016)
  4. 2022 (1152)
  5. 2021 (1088)
  6. 2020 (1257)

More Years

Publications
  1. Blood (1470)
  2. Journal of Clinical Oncology (1279)
  3. Cancer Research (1104)
  4. Clinical Cancer Research (527)
  5. Modern Pathology (494)
  6. Journal of Nuclear Medicine (474)

More Publications

Publishers
  1. Nature Publishing Group (2594)
  2. American Association for Cancer Research (2194)
  3. Elsevier Inc. (1937)
  4. American Society of Hematology (1553)
  5. Cell Press (1421)
  6. American Society of Clinical Oncology (1379)

More Publishers

Results (22468)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Adoptive treatment of EBV-associated leiomyosarcoma in immunodeficient patients with EBV specific cytotoxic T cells
    Meeting Abstract

    Prockop, S. E.; Doubrovina, E.; Boulad, F.; Kernan, N. A.; Kobos, R.; Scaradavou, A.; Abramson, S. J.; Laquaglia, M.; Price, A.; O'Reilly, R. J.
    Blood (2013)

    Fulltext@MSK | Save
  • Adoptive transfer of WT-1 specific HLA class 2 restricted donor-derived T-cells induces sustained remission of AML relapse post transplant presenting as leukemia cutis
    Meeting Abstract

    Prockop, S. E.; Doubrovina, E.; Adams, R.; Boulad, F.; Kernan, N. A.; O'Reilly, R. J.
    Blood (2013)

    Fulltext@MSK | Save
  • Phase II trial of the BRAF inhibitor, vemurafenib, in patients with BRAF mutant relapsed or refractory hairy cell leukemia
    Meeting Abstract

    Park, J. H.; Chung, S. S.; Chung, Y. R.; Won, H.; Teruya-Feldstein, J.; Berger, M.; Khawaja, T. T.; Lacouture, M. E.; Levine, R. L.; Abdel-Wahab, O.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • Msi2 directly regulates the TGF-β signaling pathway and myeloid lineage bias in hematopoietic stem cells
    Meeting Abstract

    Park, S. M.; Deering, R. P.; Lu, Y.; Patrick, T.; Shenoy, V.; Lianoglou, S.; Al-Shahrour, F.; Leslie, C.; Ebert, B. L.; Lengner, C.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • Phase I trial of autologous CD19-targeted CAR-modified T cells as consolidation after purine analog-based first-line therapy in patients with previously untreated CLL
    Meeting Abstract

    Park, J. H.; Rivière, I.; Wang, X.; Stefanski, J.; He, Q.; Borquez-Ojeda, O.; Wasielewska, T.; Taylor, C.; Qu, J.; Bartido, S.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • A bi-specific T cell engaging monoclonal antibody (mAb) derived from a TCR-Like mAB specific for WT1/HLA-A0201 (ESK-BiTE) shows a potent activity against human AML and Ph+ ALL in mouse models
    Meeting Abstract

    Pankov, D.; Dao, T.; Wang, Y.; Scott, A.; Korontsvit, T.; Zakhaleva, V.; Veomett, N.; Curcio, M.; Doubrovina, E.; O'Reilly, R. J.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • IL-22 administration decreases intestinal GVHD pathology, increases intestinal stem cell recovery, and enhances immune reconstitution following allogeneic hematopoietic transplantation
    Meeting Abstract

    Mertelsmann, A. M.; Dudakov, J. A.; Velardi, E.; Hua, G.; Kreines, F. M.; Levy, E. R.; O'Connor, M.; Smith, O. M.; Kolesnick, R.; van den Brink, M. R. M.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • Targeting oncogenic interleukein-7 receptor signaling with N-acetylcysteine in T-cell acute lymphoblastic leukemia
    Meeting Abstract

    Mansour, M. R.; Reed, C.; Eisenberg, A.; Tseng, J. C.; Yoda, A.; Rodig, S. J.; DeAngelo, D. J.; Sallan, S. E.; Weinstock, D. M.; Izraeli, S.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • Angiopoietin-like proteins stimulate HSC development through direct interaction with notch
    Meeting Abstract

    Lin, M. I.; Price, E.; Boatman, S.; Trompouki, E.; Satishchandran, S.; Carspecken, C. W.; Uong, A.; DiBiase, A.; Aster, J. C.; White, R. M.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • Pilot study to evaluate the prevalence of actionable oncogenic mutations in patients with relapsed refractory multiple myeloma
    Meeting Abstract

    Lesokhin, A.; Gonen, M.; Redling, K.; Lendvai, N.; Hassoun, H.; Landau, H.; Chung, D. J.; Koehne, G.; Patel, M.; Brennan, K. W.; more...
    Blood (2013)

    Fulltext@MSK | Save